FCC
REGN icon

Flower City Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Flower City Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Buy
+500
New +$340K 0.14% 36
2025
Q3 		– Sell
-500
Closed -$263K – 44
2025
Q2 		$263K Buy
+500
New +$279K 0.15% 33

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Flower City Capital's REGN Position: Q2 2026 in Review

Flower City Capital opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 500 shares worth $312K. The stake represents 0.14% of the portfolio and ranks #36 among its holdings. This is a return to the name: Flower City Capital previously reported a position in REGN as recently as Q2 2025.

Flower City Capital first reported a position in REGN in Q2 2025 and has held it in 2 quarters since. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Flower City Capital held 500 shares of Regeneron Pharmaceuticals worth $312K as of Q2 2026.
  • Regeneron Pharmaceuticals was a new Flower City Capital position in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.14% of Flower City Capital's portfolio in Q2 2026, its #36 holding.
  • Flower City Capital first reported a position in Regeneron Pharmaceuticals in Q2 2025 and has held it in 2 quarters since.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Flower City Capital's 13F filing for Q2 2026, filed 7 Jul 2026.